Evicenter
P&T meetings

Dersimelagon (MT-7117)

Erythropoietic protoporphyria or X-linked protoporphyria

Manufacturer
LEO Pharma
Regulatory submission
NDA submitted June 2026
Last updated
100 sources

Product information and disease descriptionProduct descriptionProduct information

Dosage forms and strengths

3 evidence topics · 4 sources

Commercial tablet strengths

No evidence found.